Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Total 13F shares
-
131,083
-
Share change
-
+11,269
-
Total reported value
-
$485,000
-
Price per share
-
$3.69
-
Number of holders
-
10
-
Value change
-
+$39,624
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2019
As of 30 Sep 2019,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,083 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, STIFEL FINANCIAL CORP, VANGUARD GROUP INC, BlackRock Inc., BANK OF MONTREAL /CAN/, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and TCI Wealth Advisors, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.